Co-Founder Michael Klichinsky, PharmD Presents at American Association for Cancer Research Annual Meeting

Research on chimeric antigen receptor macrophages by CARMA Therapeutics co-founders Dr. Klichinsky and Dr. Gill drew significant interest at the AACR Annual Meeting in Washington, DC, April 1-5, 2017. The presented data demonstrate CARMA anti-tumor function in pre-clinical models of disseminated metastatic solid tumors.

Read More Here

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s